商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ACETAMINOPHEN AND IBUPROFEN | 218359 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2024/03/26 | 2024/03/26 | AUROBINDO PHARMA LTD | Over-the-counter |
ACETAMINOPHEN AND IBUPROFEN | 218311 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2024/04/26 | 2024/04/26 | GLENMARK PHARMS LTD | Over-the-counter |
ACETAMINOPHEN AND IBUPROFEN | 218247 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2024/08/23 | 2024/08/23 | DR REDDYS | Over-the-counter |
ACETAMINOPHEN AND IBUPROFEN | 217241 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2025/01/17 | 2025/01/17 | STRIDES PHARMA | Over-the-counter |
ACETAMINOPHEN | 219215 | 001 | ANDA | ACETAMINOPHEN | SOLUTION;INTRAVENOUS | 500MG/50ML (10MG/ML) | No | No | 2025/04/02 | 2025/04/02 | GLAND | Prescription |
ACETAMINOPHEN | 219215 | 002 | ANDA | ACETAMINOPHEN | SOLUTION;INTRAVENOUS | 1GM/100ML (10MG/ML) | No | No | 2025/04/02 | 2025/04/02 | GLAND | Prescription |